Patient P-03336

Synthetic patientONX-7 · Day 111 · 35–44 · F · baseline S02Steering view · 3D Open companion preview

Therapy response

Unstable

Tolerance

Improving

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Favorable

Discontinuation risk

20%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 ONX-7 started — Baseline state S02
Day 21 Trajectory diverged from prediction — Observed response fell below the model's expected path.
Day 58 SC-12 recommended — Supportive Compound SC-12
Day 59 Patient accepted — Started SC-12 in the companion
Day 65 No meaningful change — Supportive Compound SC-12

What changed?

Trajectory began diverging from predicted response on Day 21.

Primary contributors, last 14 days

GI instability+7
Toxicity-6
Inflammatory activity+5
Nutritional resilience-3
Treatment adherence-3

What helped?

Supportive Compound SC-12Day 58
Result: no meaningful change

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level

Daily log

5.7/10

improving · +1.0 vs previous 14 d

Stress level

Daily log

3.6/10

improving · -1.3 vs previous 14 d

Pessimism score

Daily log

4.8/10

improving · -0.6 vs previous 14 d

Sleep quality

Wearable

37.2/100

improving · +7.5 vs previous 14 d

Libido

Daily log

5.6/10

improving · +1.0 vs previous 14 d

HRV

Wearable

41.4 ms

improving · +5.1 vs previous 14 d

Toxicity

Blood

0/100

improving · -11.7 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 65 from the failing basin, 47 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -4.5 next day on high-intake days · n 23

Would not help

AD-05 Adherence Support
only 29% improved among 14 similar
SC-12 Supportive Compound
already tried, no meaningful change
Keep histamine low
GI +6.2 next day on high-intake days · n 18
Keep lactose low
GI +3.5 next day on high-intake days · n 19

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Histamine load
+6.2detractor · 95%
Protein
-4.5supporter · 95%
Lactose
+3.5detractor · 72%
Alcohol
-1.1no signal · 23%
Caffeine
+0.8no signal · 15%
Dietary fat load
-0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
Autonomic recovery ↓20
- Wearable3,950 steps/day

DNA

Fictional pharmacogenomic panel

FUT2 rs601338 AA (non-secretor)
Reduced mucosal fucosylation
CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 4.1 · butyrate capacity 75/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 44 ms
Sleep: 7.3 h
Steps: 4,352
Resting HR: 57 bpm

Daily log: GI score 22, nutritional resilience 69, adherence 83.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-03235	44%	S13	GI-04	improved	29
P-03013	36%	S07	GI-04	improved	30
P-03373	36%	S17	BR-03	improved	34
P-03307	35%	S03	ME-01	improved	17
P-03380	35%	S16	AD-05	improved	34
P-03277	34%	S14	BR-03	improved	41
P-03426	34%	S18	BR-03	improved	27
P-03204	33%	S16	AD-05	improved	48
P-03233	33%	S19	DT-01	improved	47
P-03424	32%	S12	AD-05	improved	41
P-03441	32%	S19	AD-05	improved	37
P-03144	31%	S16	HY-01	improved	52